Safety of F14 Following Total Knee Replacement

NCT04860635 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

SUSPENDED

Status

100

Enrollment

INDUSTRY

Sponsor class

Stopped Study superseded by alternative Phase 3 trial

Conditions

Analgesia

Interventions

DRUG: F14 (sustained release celecoxib)

Sponsor

Arthritis Innovation Corporation